Medications for Acute Lymphocytic Leukemia

7 results
  • asparlas - calaspargase pegol injection, solution

    (Calaspargase Pegol)
    Servier Pharmaceuticals Llc
    Asparlas is an asparagine-specific enzyme used as part of combination chemotherapy to treat acute lymphoblastic leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years.
  • besponsa - inotuzumab ozogamicin injection, powder, lyophilized, for solution

    (Inotuzumab Ozogamicin)
    Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
    Besponsa treats relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adults and pediatric patients aged 1 year and older.
  • leukine - sargramostim injection, powder, lyophilized, for solution

    (Sargramostim)
    Partner Therapeutics, Inc.
    Leukine is a leukocyte growth factor used to shorten neutrophil recovery after AML chemotherapy in adults 55+, mobilize stem cells for transplant, accelerate myeloid reconstitution after bone marrow or progenitor cell transplantation, treat delayed neutrophil recovery or graft failure, and increase survival after myelosuppressive radiation exposure.
  • oncaspar - pegaspargase injection, solution

    (Pegaspargase)
    Servier Pharmaceuticals Llc
    Oncaspar is an asparagine-specific enzyme used as part of combination chemotherapy for first-line treatment of acute lymphoblastic leukemia (ALL) in pediatric and adult patients, including those with hypersensitivity to native forms of L-asparaginase.
  • rituxan - rituximab injection, solution

    (Rituximab)
    Genentech, Inc.
    Rituxan treats Non-Hodgkin's Lymphoma (adults and pediatric patients 6+ months), Chronic Lymphocytic Leukemia, moderately-to-severely active Rheumatoid Arthritis unresponsive to TNF antagonists, Granulomatosis with Polyangiitis and Microscopic Polyangiitis (ages 2+), and moderate-to-severe Pemphigus Vulgaris in adults.
  • rylaze - asparaginase erwinia chrysanthemi

    (Asparaginase Erwinia Chrysanthemi (Recombinant)-Rywn)
    Jazz Pharmaceuticals, Inc.
    Rylaze is used as part of combination chemotherapy to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.
  • xatmep - methotrexate solution

    (Methotrexate)
    Azurity Pharmaceuticals, Inc.
    Xatmep treats pediatric acute lymphoblastic leukemia (ALL) as part of combination chemotherapy maintenance, and manages polyarticular juvenile idiopathic arthritis (pJIA) in children who have not responded to or cannot tolerate first-line therapy.